The kynurenine pathway in neuroinflammatory diseases: Translation to prognostics and therapeutics

  • Guillemin, Gilles (Primary Chief Investigator)

    Project: Other

    Project Details


    My research program for the next 5 years aims to assess:
    1) How we can use small molecules present in the blood as biomarkers to evaluate disease severity, progression rate and response to treatment for neurodegenerative diseases (Prognostics);
    2) How we can alter the expression of enzymes with existing and/or newly developed drugs for the treatment of neurodegenerative diseases (Therapeutics).
    Effective start/end date1/01/2031/12/24